Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks

Acta Ophthalmol. 2010 May;88(3):e100-1. doi: 10.1111/j.1755-3768.2009.01754.x. Epub 2009 Nov 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / administration & dosage*
  • Angioid Streaks / complications*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Choroidal Neovascularization / physiopathology
  • Coloring Agents
  • Female
  • Fluorescein Angiography
  • Humans
  • Indocyanine Green
  • Injections
  • Ranibizumab
  • Visual Acuity
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Coloring Agents
  • Indocyanine Green
  • Ranibizumab